Biogen’s higher Spinraza dose shows better efficacy in Phase II/III trial
Biogen plans to apply for regulatory approval of this investigational dose regimen following positive trial data.
09 September 2024
Biogen plans to apply for regulatory approval of this investigational dose regimen following positive trial data.
The company had focused its resources on Filspari’s launch in IgAN after the US FDA snubbed the therapy in another rare kidney disorder.
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
A study suggests that children may face a higher risk of harm if their father is using valproate at the time of conception.
The company secured $67m in the Series B financing round jointly led by Ascenta Capital and Woodline Partners.
MM-II reduces joint friction and wear, thereby alleviating pain.
The latest funding takes the Series B total to £43.25m.
APP13007 is the first US FDA-approved ophthalmic solution featuring the super-potent corticosteroid clobetasol propionate.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
Give your business an edge with our leading industry insights.